FCPM III Services B.V.
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), FCPM III Services B.V. reported 8 stock positions worth $369.2 million. Its top holding was Newamsterdam Pharma (NAMS) at 52.2% of the portfolio, followed by Dyne Therapeutics (DYN, 14.1%) and Replimune (REPL, 9.8%). Compared with Q1 2025, it opened 1 new position, added to 1 and reduced 1. The biggest buy was Astria Therapeutics (ATXS, shares +7%) and the biggest sale Newamsterdam Pharma (NAMS, shares −3%).
- Most Recent 13F
- Q2 2026
- Location
- NAARDEN, P7
- CIK
- 0002013410
- Portfolio Value
- $369.2M (Q2 2025)
- SEC Filing
- 0000950123-25-008060 ↗ filed Aug 14, 2025
Holdings Value
Holdings 8 stocks · $369.2M
| NAMS Newamsterdam Pharma Co. NV | 52.16% | 10,632,113 | $192.5M | Reduce -2.8% |
| DYN Dyne Therapeutics Inc. | 14.09% | 5,462,846 | $52.0M | No change |
| REPL Replimune Group Inc. | 9.84% | 3,909,696 | $36.3M | No change |
| ENGN Engene Holdings Inc. | 9.50% | 9,632,561 | $35.1M | No change |
| BCYC Bicycle Therapeutics PLC-ADR | 6.50% | 3,452,330 | $24.0M | No change |
| ATXS Astria Therapeutics Inc. | 6.34% | 4,107,537 | $23.4M | Add +7.5% |
| RAPT Rapt Therapeutics Inc. | 0.93% | 440,176 | $3.5M | New |
| ENGENE HOLDINGS INC | 0.64% | 2,878,148 | $2.4M | No change |
Portfolio Sells Q1 2025 → Q2 2025
| NAMS Newamsterdam Pharma Co. NV | Reduce -2.8% | 52.16% | −1.95 |
Portfolio Buys Q1 2025 → Q2 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $750.4M | NAMS, MPLT, DYN, VOR, DMRA |
| Q1 2026 | 10 | $722.2M | NAMS, DYN, VOR, ENGN, MPLT |
| Q4 2025 | 10 | $762.9M | NAMS, DYN, ENGN, RAPT, MPLT |
| Q3 2025 | 9 | $500.4M | NAMS, DYN, ENGN, ATXS, BCYC |
| Q2 2025 | 8 | $369.2M | NAMS, DYN, REPL, ENGN, BCYC |
| Q1 2025 | 7 | $413.7M | NAMS, DYN, ENGN, REPL, BCYC |
| Q4 2024 | 8 | $592.4M | NAMS, DYN, ENGN, BCYC, REPL |
| Q3 2024 | 7 | $582.3M | DYN, NAMS, ENGN, REPL, BCYC |
| Q2 2024 | 7 | $678.1M | DYN, NAMS, ENGN, REPL, BCYC |
| Q1 2024 | 6 | $707.3M | NAMS, DYN, ENGN, REPL, ENGENE HOLDINGS INC |